Kisspeptin

Kisspeptin is a neuroendocrine peptide studied for GnRH activation, reproductive-hormone signaling, and fertility-related endocrine support.

Profile · 01

Overview

Kisspeptin, also called metastin in some literature, is a naturally occurring neuroendocrine peptide that activates GnRH neurons through KISS1R or GPR54 signaling. It is not FDA-approved for routine therapeutic use, but it has meaningful human reproductive-endocrinology research behind it.

The source treats Kisspeptin as a more physiologic upstream reproductive signal than direct hCG or direct GnRH analog use, while also cautioning that prolonged continuous exposure may lead to tachyphylaxis.

At a Glance

Goal
Support physiologic GnRH activation, reproductive-hormone signaling, and fertility-oriented endocrine balance
Categories
Hormone OptimizationFertilityReproductive HealthEndocrine Support
Synergistic
GnRH analogs · HCG · Clomiphene · DHEA
Profile · 02

Protocol

Suggested daily titration approach starting at 100 mcg and increasing after the first two weeks.

Reconstitute
Add 3.0 mL bacteriostatic water to a 10 mg vial for about 3.33 mg/mL concentration
Typical daily range
100-200 mcg once daily
Start
100 mcg daily for Weeks 1-2
Target
200 mcg daily by Weeks 3-12
Frequency
Once per day (subcutaneous)
Cycle Length
8-12 weeks with optional extension to 16 weeks
Timing
Any consistent time; rotate injection sites
Route
Subcutaneous
Cycle
8-12 weeks on, 4 weeks off

Inject once daily subcutaneously using a very small-volume dilution. Because Kisspeptin works through the body’s own GnRH pathway, the protocol is framed as more physiologic than direct downstream stimulation. The tradeoff is that continuous long-term use may reduce responsiveness over time.

Dose progression

Weeks 1-2
100 mcg (0.1 mg) · 3 units (0.03 mL)
Weeks 3-8
200 mcg (0.2 mg) · 6 units (0.06 mL)
Weeks 9-12
200 mcg (0.2 mg) · 6 units (0.06 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How Kisspeptin works.

Kisspeptin activates KISS1R or GPR54 receptors on GnRH neurons, which increases GnRH release and then drives pituitary LH and FSH secretion. In practical terms, it works upstream of gonadotropins and sex steroids rather than replacing them directly.

Human studies have explored Kisspeptin in IVF-trigger settings and hypothalamic amenorrhea, with some evidence of more physiologic or lower-risk endocrine signaling than direct hCG triggering in certain reproductive contexts. Broader long-term use remains less well characterized.

Science · 02

Effects

Observations from clinical or preclinical literature.

Supports endogenous LH and FSH release through upstream GnRH activation
May support testosterone or estrogen production in a more physiologic pattern than direct downstream replacement
Has meaningful human reproductive-endocrinology research in IVF and hypothalamic-amenorrhea contexts
Generally well tolerated in published clinical studies at researched doses
Mild injection-site irritation may occur
Continuous prolonged exposure may lead to tachyphylaxis or reduced responsiveness
Science · 03

Caution

Use caution in hormone-sensitive cancers because downstream sex-steroid production may increase
Not recommended during pregnancy or breastfeeding because safety data is insufficient
Avoid prolonged uncycled use if loss of responsiveness is a concern
Individuals with hypothalamic or pituitary disorders should only use this type of protocol under specialist supervision

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Zinc
Supports testosterone synthesis and reproductive signaling.
Vitamin D
Relevant to fertility and reproductive endocrine balance.
Magnesium
Supports sleep, recovery, and enzymatic hormonal physiology.
Selenium
Supports thyroid and reproductive health.
Folate
Relevant to fertility and gametogenesis-related biology.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Maintain adequate energy availability and healthy body weight because both low and high energy states can impair reproductive signaling
Avoid overtraining because excessive stress and energy deficit can suppress GnRH pulsatility
Prioritize 7-9 hours of sleep for endocrine stability
Manage chronic stress because cortisol excess can suppress reproductive-hormone output
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Libido and sexual-function trends - useful practical proxies for sex-hormone shifts
  2. Menstrual regularity in females - helpful where reproductive cycling is a target outcome
  3. Energy and mood - often track with improved endocrine balance
  4. Injection-site reactions - note redness, swelling, or discomfort
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

LH
Primary gonadotropin response marker for upstream Kisspeptin signaling.
FSH
Useful alongside LH for broader reproductive-axis interpretation.
Total and free testosterone / estradiol
Downstream sex-steroid markers depending on sex and context.
SHBG
Helpful for interpreting free-hormone status.
CBC (Complete Blood Count)
General monitoring and baseline screening.
CMP (Comprehensive Metabolic Panel)
Assess broader systemic function during the protocol.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 10 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Rotate sites across the abdomen, thighs, upper arms, or upper buttocks to reduce local irritation
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely
This is a very low-volume injection protocol, so smaller-capacity syringes may improve accuracy
Kisspeptin is being used as an upstream endocrine signal rather than a direct gonadotropin replacement
Avoid prolonged continuous use without thoughtful cycling if responsiveness begins to fade
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. JCEM
    Kisspeptin-54 stimulation of the HPG axis in human males.
    https://pubmed.ncbi.nlm.nih.gov/16174713/
  2. NEJM
    Kisspeptin administration in women with hypothalamic amenorrhea.
    https://pubmed.ncbi.nlm.nih.gov/25162887/
  3. Journal of Clinical Investigation
    Kisspeptin as an IVF trigger and clinical safety discussion.
    https://pubmed.ncbi.nlm.nih.gov/26389681/
  4. Endocrine Reviews
    The Kisspeptin-GnRH pathway in reproductive health and disease.
    https://pubmed.ncbi.nlm.nih.gov/24735424/
  5. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
On this page